Accordingly, the proportion of subjects with an Adpn/Lep ratio below the lower cut-off point proposed (and considered as of high cardiometabolic risk) is significantly higher in individuals with obesity, T2D or the MS. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.